The Vaccine Trust Problem

At the front lines of the Ebola crisis in Central Africa, badly equipped health workers with little outside support are losing the fight against one of the worst outbreaks in history. Declan Walsh, a New York Times correspondent covering the outbreak, takes us to the epicenter of ...  Show more

SpaceX, Elon Musk’s rocket and satellite maker, is set to go public and begin selling shares as soon as next week. Ryan Mac, who reports on business, explains the plan for the company’s expected record-shattering debut on the stock market, and how it is changing the rules for inv ...  Show more

As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ...  Show more

On the same day the COVID-19 death toll surpassed 300,000 in the United States, the first vaccines are being administered, finally giving millions of Americans hope for a better future and a return to normalcy. We explore how officials expect to deliver a safe and effective vacci ...  Show more

The first in an unfolding miniseries - The Vaccine - tracking the progress of those tackling this historic challenge. We'll be making sense of the latest developments as they happen, taking an inside look at the vaccine industry, and learning from ...

A recent vaccine trial from Oxford University shows promising preliminary results, suggesting the vaccine can produce immune responses that may protect people against infection. Dr. Sanjay Gupta spoke with Dr. Barney Graham, the deputy director of the Vaccine Research Center at t ...  Show more